TrialThe European respiratory journal2024

Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial).

Nick H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.